A Clinical Study of ONO-1110 in Patients With Fibromyalgia (NCT06752590) | Clinical Trial Compass
Active — Not RecruitingPhase 2
A Clinical Study of ONO-1110 in Patients With Fibromyalgia
Japan160 participantsStarted 2025-03-26
Plain-language summary
To Evaluate the Efficacy and Safety of ONO-1110 in Patients with Fibromyalgia
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Japanese (both sexes)
* Outpatient
* Patients who are considered capable of understanding the study procedures and completing the pain diary and questionnaires appropriately by the investigator (sub-investigator)
* Patients who meet the American College of Rheumatology Fibromyalgia Criteria
Exclusion Criteria:
* Patients with inflammatory arthritis, infectious arthritis, or autoimmune disease
* Patients with pain other than FM that may affect assessments in this study
* Patients with a past history of or concurrent neurologic diseases that may affect assessments in this study
* Patients with a past history of or concurrent malignant tumor within 3 years
* Patients who are pregnant, nursing, or possibly pregnant, or intending to become pregnant during the study period.
What they're measuring
1
Change in weekly mean of average pain score from baseline to Week 8 of the treatment period